Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Liminatus Pharma, Inc. (LIMN) — insider transactions · InsiderLens

Home / Companies / Liminatus Pharma, Inc.

Liminatus Pharma, Inc.

LIMN

Insider trading at Liminatus Pharma, Inc.

No insider transactions on record for Liminatus Pharma, Inc..

Current insiders at Liminatus Pharma, Inc.

Baek Ji YeonDirector
Baek Richard JaiHwanDirector
Choi Beom KyuChief Technology Officer
Dam ScottChief Financial Officer
Ewon Comfortech Co., Ltd.10% owner
Fernandez NicholasDirector
Iris Acquisition Holdings LLC10% owner
KH Feelux Co., Ltd10% owner
Kim ChrisDirector
Kim ChrisChief Executive Officer
Kim Chris10% owner
Lee Eun SookDirector
Lee Sang-JinHead of Research & Development
Lemons II Philip WayneDirector
Valetudo Therapeutics LLC10% owner
Yoo Byong ChulChief Science Officer

Insider transaction history at Liminatus Pharma, Inc.

Insider	Filed	Type	Qty	Price	Value · USD	Src
Valetudo Therapeutics LLC	Jul 6, 2026	Other	-4,373,603	—	—	SEC